Items where Author is "Kanji, Rahim"
Number of items: 14.
Article
Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024)
Ying X. Gue,
Vassilios Memtsas,
Rahim Kanji,
David Wellsted,
Amanda Busby,
Megan Smith,
Enric Vilar,
Alisdair Ryding,
Deepa J. Arachchillage
and
Diana Gorog
Measuring thrombus stability at high shear, together with thrombus formation and endogenous fibrinolysis: first experience using the Global Thrombosis Test 3 (GTT-3). (2023)
Rahim Kanji,
Joshua Leader,
Vassilios Memtsas
and
Diana Gorog
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. (2023)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas,
Neil H. Spencer
and
Diana Gorog
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. (2022)
Rahim Kanji,
Ying X. Gue,
Mohamed F. Farag,
Neil H. Spencer,
Nicola J. Mutch
and
Diana A. Gorog
Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation. (2021)
Rahim Kanji,
Christophe Vandenbriele,
Deepa R.J Arachchillage,
Susanna Price
and
Diana Gorog
Fibrinolysis in platelet thrombi. (2021)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas
and
Diana Gorog
Thrombotic complications in 2,928 patients with COVID-19 treated in intensive care: a systematic review. (2021)
William Jenner,
Rahim Kanji,
Saeed Mirsadraee,
Ying X. Gue,
Susanna Price,
Sanjay Prasad
and
Diana Gorog
Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment. (2020)
Rahim Kanji,
Jacek Kubica,
Eliano P Navarese
and
Diana Gorog
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. (2020)
Ying X. Gue,
Maria Tennyson,
Jovia Gao,
Shuhui Ren,
Rahim Kanji
and
Diana A. Gorog
Angiotensin Converting Enzyme 2 may mediate disease severity in COVID-19. (2020)
Ying X. Gue,
Rahim Kanji
and
Diana Gorog
Usefulness of the NULL-PLEASE Score to predict 1 survival in out-of hospital cardiac arrest. (2020)
Ying Gue,
Max Sayers,
Benjamin Whitby,
Rahim Kanji,
Krishma Adatia,
Robert Smith,
William Davies,
Aris Perperoglou,
Tatjana Potpara,
Gregory Y H Lip
and
Diana Gorog
MINOCA presenting with STEMI- a review of incidence, aetiology, assessment and treatment. (2020)
Ying X. Gue,
Rahim Kanji,
Sabiha Gati
and
Diana Gorog
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. (2019)
Ying X Gue,
Rahim Kanji,
David M Wellsted,
Manivannan Srinivasan,
Solange Wyatt
and
Diana A Gorog